IT vs RIGL · P/E 16, rev $6.27B vs P/E 9.1, rev $179.3M
Gartner Inc (IT) versus Rigel Pharmaceuticals Inc (RIGL) — a side-by-side from cached financials, not a winner call.
Gartner Inc (IT) is a information technology services company listed on US.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Latest reported RIGL revenue for 2024-12-31 was $179.3M. Net income was $17.5M. Revenue was up 53.4% from 2023-12-31 to 2024-12-31. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
IT currently screens at market cap $11.03B and trailing P/E 16.3. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Not investment advice. Open the IT and RIGL stock pages for the full models.
Not investment advice.